RSABE with two test products [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2023-08-23 12:01 (327 d 17:09 ago) – Posting: # 23705
Views: 2,531

Hi Darborn,

❝ When design a crossover trial with two test drug (or one ODT given with/without water), I run into confusion about how to give a balanced design for the trial.


If the design is not reference-replicated, easy. See this article.

❝ Furthermore, which make things even worse, I always get confused by "variance-balanced" and "carryover-balance" design.


True unequal carryover will bias the treatment effect. It cannot be “corrected” statistically. It can only be avoided by sufficiently long washouts. See this article. Carryover is not included in the current models for BE. Since sample sizes for a conventional Latin Squares and (variance-balanced) Williams’ designs are similar,* you can use any of them.

❝ I came out with the following design, but I'm not sure if it is suitable to use when analyzed with FDA RSABE approach.

    T1  R   T2   R

    R   T1  R   T2

    T2  R   T1  R

    R   T2  R   T1


First of all you have to receive a positive statement from the FDA in a “Controlled Correspondence” because this is not one of the recommended designs for RSABE.
According to ICH M13A you have to exclude treatments (T1 or T2) and perform two separate analyses on the respective others (T1 vs R and T2 vs R). Your design will lead to two partial replicate designs with missing observations (denoted with below):

  1. T1  R   •   R
    R   T1  R   •
    •   R   T1  R
    R   •   R   T1



  2. •   R   T2  R
    R   •   R   T2
    T2  R   •   R
    R   T2  R   •
So far I’ve done that only in pilot studies (deciding which of two candidate formulations should be used in a pivotal study). Drawback: You have to assume CVwT = CVwR because in partial replicate designs CVwT is unknown. If CVwT < CVwR (quite often), your study will be overpowered and economically questionable. If CVwT > CVwR your study will be underpowered (higher risk of failure). Both cases are ethically questionable.



Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,101 posts in 4,857 threads, 1,644 registered users;
62 visitors (0 registered, 62 guests [including 6 identified bots]).
Forum time: 05:11 CEST (Europe/Vienna)

One can show the following: given any rule, however “fundamental”
or “necessary” for science, there are always circumstances
when it is advisable not only to ignore the rule,
but to adopt its opposite.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5